Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Neuroone Medical Technologies (NMTC) Other Non Operating Income (2022 - 2025)

Neuroone Medical Technologies (NMTC) has disclosed Other Non Operating Income for 4 consecutive years, with $46677.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Other Non Operating Income rose 396.14% year-over-year to $46677.0, compared with a TTM value of $207761.0 through Dec 2025, up 133.41%, and an annual FY2025 reading of $170492.0, up 36.2% over the prior year.
  • Other Non Operating Income was $46677.0 for Q4 2025 at Neuroone Medical Technologies, down from $66594.0 in the prior quarter.
  • Across five years, Other Non Operating Income topped out at $75432.0 in Q2 2025 and bottomed at -$26909.0 in Q1 2023.
  • Average Other Non Operating Income over 4 years is $33700.5, with a median of $31008.0 recorded in 2024.
  • The sharpest move saw Other Non Operating Income plummeted 79.36% in 2024, then soared 396.14% in 2025.
  • Year by year, Other Non Operating Income stood at $51583.0 in 2022, then fell by 11.65% to $45575.0 in 2023, then tumbled by 79.36% to $9408.0 in 2024, then skyrocketed by 396.14% to $46677.0 in 2025.
  • Business Quant data shows Other Non Operating Income for NMTC at $46677.0 in Q4 2025, $66594.0 in Q3 2025, and $75432.0 in Q2 2025.